Furthermore, EpCAM enhances proliferation rates of carcinoma cells [34],[40], presumably mediated via direct nuclear signaling of its proteolytically cleaved intracellular domain EpICD [41], and via c-Myc and the cell cycle regulators cyclin A and E [42]–[44]. This evidence concerns the gene EPCAM and carcinoma.